Legal Advantage Investments’s AstraZeneca AZN Stock Holding History

Legal Advantage Investments’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$329K	Hold	1,737	–	–	0.12%	71
2026 Q1	$343K	Sell	1,737 -1	-0.1%	-$193	0.18%	71
2025 Q4	$319K	Sell	1,738 -37	-2%	-$6.49K	0.15%	79
2025 Q3	$272K	Hold	1,775	–	–	0.12%	84
2025 Q2	$248K	Sell	1,775 -100	-5%	-$14K	0.12%	90
2025 Q1	$276K	Sell	1,875 -100	-5%	-$14.5K	0.15%	90
2024 Q4	$259K	Sell	1,975 -100	-5%	-$14K	0.14%	93
2024 Q3	$323K	Sell	2,075 -100	-5%	-$16.1K	0.18%	84
2024 Q2	$339K	Hold	2,175	–	–	0.2%	81
2024 Q1	$295K	Hold	2,175	–	–	0.16%	89
2023 Q4	$293K	Sell	2,175 -100	-4%	-$13K	0.18%	88
2023 Q3	$308K	Sell	2,275 -125	-5%	-$17.1K	0.22%	78
2023 Q2	$344K	Hold	2,400	–	–	0.23%	81
2023 Q1	$333K	Hold	2,400	–	–	0.24%	79
2022 Q4	$325K	Hold	2,400	–	–	0.27%	74
2022 Q3	$263K	Hold	2,400	–	–	0.25%	73
2022 Q2	$317K	Hold	2,400	–	–	0.31%	64
2022 Q1	$318K	Hold	2,400	–	–	0.24%	68
2021 Q4	$280K	Hold	2,400	–	–	0.19%	72
2021 Q3	$288K	Hold	2,400	–	–	0.19%	73
2021 Q2	$288K	Hold	2,400	–	–	0.2%	72
2021 Q1	$239K	Hold	2,400	–	–	0.18%	72
2020 Q4	$240K	Buy	+2,400	New	+$254K	0.19%	71

Other funds holding AZN

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Legal Advantage Investments's AZN Position: Q2 2026 in Review

Legal Advantage Investments held its AstraZeneca (AZN) position steady in Q2 2026 at 1,737 shares worth $329K. The position accounts for 0.12% of the portfolio, ranked #71.

Legal Advantage Investments first reported a position in AZN in Q4 2020 and has held it in 23 quarters since. The position peaked at $344K in Q2 2023. 758 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Legal Advantage Investments held 1,737 shares of AstraZeneca worth $329K as of Q2 2026.
Legal Advantage Investments left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.12% of Legal Advantage Investments's portfolio in Q2 2026, its #71 holding.
Legal Advantage Investments first reported a position in AstraZeneca in Q4 2020 and has held it in 23 quarters since.
Legal Advantage Investments's AstraZeneca position peaked at $344K in Q2 2023.
758 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Legal Advantage Investments's 13F filing for Q2 2026, filed 15 Jul 2026.